ClearTrial Launches New Service to Bring Speed and Accuracy in Clinical Trial Planning Within Reach of Smaller Biopharma Companies

March 3, 2010

Company News Release

ClearTrial today unveiled the ClearTrial Study Costing & Optimization Service (SCOS), a service that provides greater visibility and control over clinical trial costs, resources, and timelines for smaller biopharma companies. The ClearTrial SCOS delivers a combination of ClearTrial software and ClearTrial’s Clinical Services personnel to bring greater speed and accuracy to clinical trial planning.

"Many smaller biopharma companies lack the visibility to accurately forecast clinical trials, leading to them not understanding how much clinical trials should really cost, as well as dealing with unforeseen shifts in trial timelines," noted Andrew Grygiel, Vice President of Marketing and Product Management for ClearTrial.

During the ClearTrial SCOS, a ClearTrial Clinical Services Manager (CSM) acts as an extension of a company's internal clinical team. The ClearTrial CSM works with that team to fully understand the study's design, objectives, and clinical assumptions, then leverages the industry intelligence and activity-based planning methodology of the ClearTrial software to generate detailed and accurate cost, resource, and timeline reports for multiple study scenarios. These scenarios enable the ClearTrial CSM and the company's team to perform "what-if" analyses for cutting cost, time, or both from a study.

"As the cost and timeline pressures continue to grow, organizations large and small must ensure that their clinical trial dollars are being spent as effectively as possible," stated ClearTrial CEO Mike Soenen. "We're pleased to be able to help our industry achieve this goal by introducing the ClearTrial Study Costing & Optimization Service to the market."

Related Content:

News